Clinical Trial Update: Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a chemotherapy combination with autologous cell immunotherapy for advanced lung cancer is ongoing, with status currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: IIIB/IIIC/IV Lung Cancer | Phase 3 | Status: UNKNOWN